Amgen cancer drug Kyprolis to get expedited review from FDA
An experimental multiple myeloma treatment using Amgen’s Kyprolis will get an expedited review from the U.S. Food and Drug Administration. The FDA said it will use an expedited review process to review a multiple-myeloma treatment using Kyprolis and the genric drug dexamethasone. On July 23, Amgen submitted additional data to the FDA which compared this Read More →
Westlake Village-based Kythera Biopharmaceuticals reports second quarter loss
Westlake Village-based Kythera Biopharmaceuticals missed analyst estimates when it released second quarter earnings on Aug. 6. Kythera lost $1.44 per share, missing analyst estimates of a loss of $1.10 per share. For the quarter, Kythera lost $37.2 million, compared to $19.5 million during the second quarter of 2014. On June 17, Allergan announced that it Read More →
Dubroff: Washington dysfunction over taxes could cost jobs in Tri-Counties
This is a column about how dysfunction in Washington is handing billions over to Wall Street while threatening thousands of jobs on the Central Coast. Just a year ago, Allergan shut its Goleta breast implant operation after it came under siege from corporate raiders, Activis, a New Jersey-based company that used an acquisition in Ireland Read More →
Economic development should be part of Ventura County’s general plan
Ventura County is embarking on an important step forward as it weighs the latest update to its general plan. That step would be to include an economic development element to the general plan in the next approval cycle. A letter to county officials from the Economic Development Collaborative of Ventura County recommends the county include Read More →